These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 6608368)
21. Immunotyping of blasts in refractory anaemia with excess of blasts. Oertel J; Kleiner S; Huhn D Br J Haematol; 1993 Jun; 84(2):305-9. PubMed ID: 7691147 [TBL] [Abstract][Full Text] [Related]
22. Increased expression of c-myc p67 oncoprotein in patients with myelodysplastic syndromes in transformation to acute leukaemia. Kyriakou D; Eliopoulos AG; Alexandrakis M; Kalokyri I; Eliopoulos GD Haematologia (Budap); 1996; 28(1):1-7. PubMed ID: 9283897 [TBL] [Abstract][Full Text] [Related]
23. Myelodysplastic syndromes: analysis of 131 cases according to the FAB classification. Economopoulos T; Stathakis N; Foudoulakis A; Papadoulis N; Dervenoulas J; Papageorgiou E; Anastassiou C; Hadjioannou J; Raptis S Eur J Haematol; 1987 Apr; 38(4):338-44. PubMed ID: 3609254 [TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in adult de novo myelodysplastic syndromes treated by intensive chemotherapy. Fenaux P; Morel P; Rose C; Lai JL; Jouet JP; Bauters F Br J Haematol; 1991 Apr; 77(4):497-501. PubMed ID: 2025575 [TBL] [Abstract][Full Text] [Related]
25. Primary myelodysplastic syndrome: clinical spectrum of 53 cases. Irfan M; Kakepoto GN; Khursheed M J Pak Med Assoc; 1998 Mar; 48(3):69-73. PubMed ID: 9783031 [TBL] [Abstract][Full Text] [Related]
26. Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience. Yusuf U; Frangoul HA; Gooley TA; Woolfrey AE; Carpenter PA; Andrews RG; Deeg HJ; Appelbaum FR; Anasetti C; Storb R; Sanders JE Bone Marrow Transplant; 2004 Apr; 33(8):805-14. PubMed ID: 14755311 [TBL] [Abstract][Full Text] [Related]
27. Sequential karyotypic evolutions and bone marrow aplasia preceding acute myelomonocytic transformation from myelodysplastic syndrome. Tomonaga M; Tomonaga Y; Kusano M; Ichimaru M Br J Haematol; 1984 Sep; 58(1):53-60. PubMed ID: 6590091 [TBL] [Abstract][Full Text] [Related]
28. Refractory anaemia with excess of blasts in transformation re-evaluated with the WHO criteria: identification of subgroups with different survival. Breccia M; Latagliata R; Carmosino I; Gentilini F; D'Elia GM; Levi A; Natalino F; Frustaci A; De Cuia MR; Alimena G Acta Haematol; 2007; 117(4):221-5. PubMed ID: 17259693 [TBL] [Abstract][Full Text] [Related]
29. Characteristics of the phenotypic abnormalities of bone marrow cells in childhood myelodysplastic syndromes and juvenile myelomonocytic leukemia. Oliveira AF; Tansini A; Vidal DO; Lopes LF; Metze K; Lorand-Metze I Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27748021 [TBL] [Abstract][Full Text] [Related]
30. Diagnostic and prognostic values of in vitro culture growth patterns of marrow granulocyte-macrophage progenitors in patients with myelodysplastic syndrome. Shih LY; Chiu WF; Lee CT Leukemia; 1991 Dec; 5(12):1092-8. PubMed ID: 1774958 [TBL] [Abstract][Full Text] [Related]
31. Cytogenetic findings in the dysmyelopoietic syndrome. Kardon N; Schulman P; Degnan TJ; Budman DR; Davis J; Vinciguerra V Cancer; 1982 Dec; 50(12):2834-8. PubMed ID: 6958354 [TBL] [Abstract][Full Text] [Related]
32. Primary myelodysplasia occurring in adults under 50 years old: a clinicopathologic study of 52 patients. Chang KL; O'Donnell MR; Slovak ML; Dagis AC; Arber DA; Niland JC; Forman SJ Leukemia; 2002 Apr; 16(4):623-31. PubMed ID: 11960342 [TBL] [Abstract][Full Text] [Related]
33. [Prognostic factors in myelodysplastic syndromes: analysis of 72 cases]. Krieger O; Bernhart M; Desser H; Nowotny H; Lutz D Wien Klin Wochenschr; 1985 Feb; 97(3):131-6. PubMed ID: 3984346 [TBL] [Abstract][Full Text] [Related]
34. Classification of patients with myelodysplastic syndromes according to the FAB co-operative group's proposals. Proposals for a redefinition of blast cell type II. Nielsen B; Thiede T; Sundström C; Hagberg H Scand J Haematol; 1984 May; 32(5):531-5. PubMed ID: 6587560 [TBL] [Abstract][Full Text] [Related]
36. Quantitative evaluation of erythropoietic activity in dysmyelopoietic syndromes. Cazzola M; Barosi G; Berzuini C; Dacco M; Orlandi E; Stefanelli M; Ascari E Br J Haematol; 1982 Jan; 50(1):55-62. PubMed ID: 6948570 [TBL] [Abstract][Full Text] [Related]
37. Detection of risk groups in myelodysplastic syndromes. A multicenter study. Belli C; Acevedo S; Bengio R; Arrossagaray G; Watman N; Rossi N; García J; Flores G; Goldztein S; Larripa I Haematologica; 2002 Jan; 87(1):9-16. PubMed ID: 11801460 [TBL] [Abstract][Full Text] [Related]
38. Myelodysplastic syndromes (MDS) in Central Africans. Mukiibi JM; Paul B Trop Geogr Med; 1994; 46(1):17-9. PubMed ID: 8165730 [TBL] [Abstract][Full Text] [Related]
39. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Aul C; Gattermann N; Heyll A; Germing U; Derigs G; Schneider W Leukemia; 1992 Jan; 6(1):52-9. PubMed ID: 1736014 [TBL] [Abstract][Full Text] [Related]
40. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications. Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]